Nvidia and pharmaceutical company Eli Lilly are investing up to $1 billion over five years to establish a co-innovation lab in the San Francisco Bay Area focused on AI-assisted drug discovery. The lab will use Nvidia's BioNeMo platform and newly announced Vera Rubin GPUs to develop foundation models for biology and chemistry.
Sort: